Brief: Karuna Therapeutics Q1 net loss of USD 97.574 million
04/05/2023 13:14
May 4 (Reuters) - Karuna Therapeutics Q1 net income USD -97.574 million. * Q1 revenue USD 700 thousand
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)